How many 8-K filings has Maravai Lifesciences Holdings, Inc. filed?

Maravai Lifesciences Holdings, Inc. (MRVI) has 20 8-K (Current Event Report) filings on record, spanning Feb 2024 to Nov 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Maravai Lifesciences Holdings, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Maravai Lifesciences Holdings, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Maravai Lifesciences Holdings, Inc. (MRVI) — 8-K Filings

All 8-K filings from Maravai Lifesciences Holdings, Inc.. Browse 20 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (20)

Maravai LifeSciences Files 8-K on Financials — Nov 6, 2025 Risk: low
On November 6, 2025, Maravai LifeSciences Holdings, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial co
Maravai LifeSciences Reports Officer/Director Changes — Oct 27, 2025 Risk: medium
Maravai LifeSciences Holdings, Inc. filed an 8-K on October 27, 2025, reporting changes effective October 21, 2025. The filing indicates a departure of director
GTCR to Acquire Maravai LifeSciences for $3.4B — Jul 18, 2025 Risk: medium
Maravai LifeSciences Holdings, Inc. announced on July 16, 2025, that it has entered into a definitive agreement to be acquired by GTCR LLC. The transaction is v
Maravai LifeSciences Files 8-K: Director/Officer Changes — Jun 25, 2025 Risk: medium
Maravai LifeSciences Holdings, Inc. filed an 8-K on June 25, 2025, reporting events as of June 22, 2025. The filing covers the departure of directors, election
Maravai LifeSciences Files 8-K on Leadership Changes — Jun 9, 2025 Risk: medium
Maravai LifeSciences Holdings, Inc. filed an 8-K on June 9, 2025, reporting on the departure of directors, election of new directors, appointment of officers, a
Maravai LifeSciences Files 8-K on Shareholder Votes — May 28, 2025 Risk: low
Maravai LifeSciences Holdings, Inc. filed an 8-K on May 28, 2025, reporting on matters submitted to a vote of security holders as of May 22, 2025. The filing de
Maravai LifeSciences Files 8-K on Financials — May 12, 2025 Risk: low
Maravai LifeSciences Holdings, Inc. filed an 8-K on May 12, 2025, reporting on its financial condition and results of operations. The filing includes financial
Maravai LifeSciences Files 8-K for Regulation FD Disclosure — Mar 20, 2025 Risk: medium
Maravai LifeSciences Holdings, Inc. filed an 8-K on March 20, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the
Maravai LifeSciences Files 8-K on Financials — Feb 25, 2025 Risk: low
Maravai LifeSciences Holdings, Inc. filed an 8-K on February 25, 2025, reporting on its Results of Operations and Financial Condition, and Regulation FD Disclos
Maravai LifeSciences Appoints New Directors, Adjusts Executive Pay — Jan 8, 2025 Risk: medium
Maravai LifeSciences Holdings, Inc. announced on January 2, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the c
Maravai LifeSciences Files 8-K Report — Dec 18, 2024 Risk: low
On December 18, 2024, Maravai LifeSciences Holdings, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specifi
Maravai LifeSciences Announces Executive & Board Changes — Dec 5, 2024 Risk: medium
Maravai LifeSciences Holdings, Inc. announced on December 3, 2024, the departure of its Chief Financial Officer, William R. Floyd. The company also announced th
Maravai LifeSciences Files 8-K on Financials — Nov 7, 2024 Risk: low
Maravai LifeSciences Holdings, Inc. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition. The filing includes financ
Maravai LifeSciences Enters Material Definitive Agreement — Sep 12, 2024 Risk: medium
Maravai LifeSciences Holdings, Inc. announced on September 10, 2024, that it has entered into a material definitive agreement. The filing does not disclose spec
Maravai LifeSciences Files 8-K on Financials — Aug 7, 2024 Risk: low
Maravai LifeSciences Holdings, Inc. filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition, and including financial stat
Maravai LifeSciences Appoints Dr. William S. Merritt as CEO — Jul 29, 2024 Risk: low
Maravai LifeSciences Holdings, Inc. announced on July 23, 2024, the appointment of Dr. William S. Merritt as Chief Executive Officer, effective immediately. Dr.
Maravai LifeSciences Appoints New Directors, Adjusts CFO Compensation — Jun 12, 2024 Risk: medium
Maravai LifeSciences Holdings, Inc. announced on June 10, 2024, changes in its board of directors and executive compensation. Specifically, the company elected
Maravai LifeSciences Files 8-K on Shareholder Vote Matters — May 28, 2024 Risk: low
Maravai LifeSciences Holdings, Inc. filed an 8-K on May 28, 2024, reporting on matters submitted to a vote of security holders on May 23, 2024. The filing detai
Maravai LifeSciences Files 8-K on Financials — May 8, 2024 Risk: low
Maravai LifeSciences Holdings, Inc. filed an 8-K on May 8, 2024, reporting on its results of operations and financial condition. The filing includes financial s
Maravai LifeSciences Reports Financial Condition in 8-K Filing — Feb 22, 2024 Risk: medium
Maravai LifeSciences Holdings, Inc. filed an 8-K on February 22, 2024, to report on its results of operations and financial condition. The filing, under SEC Fil

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX